A Phase III Study for Patients With Metastatic Hormone-naïve Prostate Cancer (PEACE1)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01957436 |
Recruitment Status :
Active, not recruiting
First Posted : October 8, 2013
Last Update Posted : November 8, 2023
|
Sponsor:
UNICANCER
Collaborators:
Janssen-Cilag Ltd.
European Organisation for Research and Treatment of Cancer - EORTC
Ipsen
Sanofi
Information provided by (Responsible Party):
UNICANCER
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Actual Primary Completion Date : | August 18, 2021 |
Estimated Study Completion Date : | December 2032 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):